ATRvD1 Attenuates Renal Tubulointerstitial Injury Induced by Albumin Overload in Sepsis-Surviving Mice

Novel strategies for the prevention and treatment of sepsis-associated acute kidney injury and its long-term outcomes have been required and remain a challenge in critical care medicine. Therapeutic strategies using lipid mediators, such as aspirin-triggered resolvin D1 (ATRvD1), can contribute to t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: José Bruno N. F. Silva, Thayanne B. B. Calcia, Cyntia P. Silva, Rafael F. Guilherme, Fernando Almeida-Souza, Felipe S. Lemos, Kátia S. Calabrese, Celso Caruso-Neves, Josiane S. Neves, Claudia F. Benjamim
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/bc27d461d16249e0bfb505668ad0236d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bc27d461d16249e0bfb505668ad0236d
record_format dspace
spelling oai:doaj.org-article:bc27d461d16249e0bfb505668ad0236d2021-11-11T17:06:36ZATRvD1 Attenuates Renal Tubulointerstitial Injury Induced by Albumin Overload in Sepsis-Surviving Mice10.3390/ijms2221116341422-00671661-6596https://doaj.org/article/bc27d461d16249e0bfb505668ad0236d2021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11634https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Novel strategies for the prevention and treatment of sepsis-associated acute kidney injury and its long-term outcomes have been required and remain a challenge in critical care medicine. Therapeutic strategies using lipid mediators, such as aspirin-triggered resolvin D1 (ATRvD1), can contribute to the resolution of acute and chronic inflammation. In this study, we examined the potential effect of ATRvD1 on long-term kidney dysfunction after severe sepsis. Fifteen days after cecal ligation and puncture (CLP), sepsis-surviving BALB/c mice were subjected to a tubulointerstitial injury through intraperitoneal injections of bovine serum albumin (BSA) for 7 days, called the subclinical acute kidney injury (subAKI) animal model. ATRvD1 treatment was performed right before BSA injections. On day 22 after CLP, the urinary protein/creatinine ratio (UPC), histologic parameters, fibrosis, cellular infiltration, apoptosis, inflammatory markers levels, and mRNA expression were determined. ATRvD1 treatment mitigated tubulointerstitial injury by reducing proteinuria excretion, the UPC ratio, the glomerular cell number, and extracellular matrix deposition. Pro-fibrotic markers, such as transforming growth factor β (TGFβ), type 3 collagen, and metalloproteinase (MMP)-3 and -9 were reduced after ATRvD1 administration. Post-septic mice treated with ATRvD1 were protected from the recruitment of IBA1<sup>+</sup> cells. The interleukin-1β (IL-1β) levels were increased in the subAKI animal model, being attenuated by ATRvD1. Tumor necrosis factor-α (TNF-α), IL-10, and IL-4 mRNA expression were increased in the kidney of BSA-challenged post-septic mice, and it was also reduced after ATRvD1. These results suggest that ATRvD1 protects the kidney against a second insult such as BSA-induced tubulointerstitial injury and fibrosis by suppressing inflammatory and pro-fibrotic mediators in renal dysfunction after sepsis.José Bruno N. F. SilvaThayanne B. B. CalciaCyntia P. SilvaRafael F. GuilhermeFernando Almeida-SouzaFelipe S. LemosKátia S. CalabreseCelso Caruso-NevesJosiane S. NevesClaudia F. BenjamimMDPI AGarticlesepsisrenal tubulointerstitial injuryresolvinATRvD1inflammationkidneyBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11634, p 11634 (2021)
institution DOAJ
collection DOAJ
language EN
topic sepsis
renal tubulointerstitial injury
resolvin
ATRvD1
inflammation
kidney
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle sepsis
renal tubulointerstitial injury
resolvin
ATRvD1
inflammation
kidney
Biology (General)
QH301-705.5
Chemistry
QD1-999
José Bruno N. F. Silva
Thayanne B. B. Calcia
Cyntia P. Silva
Rafael F. Guilherme
Fernando Almeida-Souza
Felipe S. Lemos
Kátia S. Calabrese
Celso Caruso-Neves
Josiane S. Neves
Claudia F. Benjamim
ATRvD1 Attenuates Renal Tubulointerstitial Injury Induced by Albumin Overload in Sepsis-Surviving Mice
description Novel strategies for the prevention and treatment of sepsis-associated acute kidney injury and its long-term outcomes have been required and remain a challenge in critical care medicine. Therapeutic strategies using lipid mediators, such as aspirin-triggered resolvin D1 (ATRvD1), can contribute to the resolution of acute and chronic inflammation. In this study, we examined the potential effect of ATRvD1 on long-term kidney dysfunction after severe sepsis. Fifteen days after cecal ligation and puncture (CLP), sepsis-surviving BALB/c mice were subjected to a tubulointerstitial injury through intraperitoneal injections of bovine serum albumin (BSA) for 7 days, called the subclinical acute kidney injury (subAKI) animal model. ATRvD1 treatment was performed right before BSA injections. On day 22 after CLP, the urinary protein/creatinine ratio (UPC), histologic parameters, fibrosis, cellular infiltration, apoptosis, inflammatory markers levels, and mRNA expression were determined. ATRvD1 treatment mitigated tubulointerstitial injury by reducing proteinuria excretion, the UPC ratio, the glomerular cell number, and extracellular matrix deposition. Pro-fibrotic markers, such as transforming growth factor β (TGFβ), type 3 collagen, and metalloproteinase (MMP)-3 and -9 were reduced after ATRvD1 administration. Post-septic mice treated with ATRvD1 were protected from the recruitment of IBA1<sup>+</sup> cells. The interleukin-1β (IL-1β) levels were increased in the subAKI animal model, being attenuated by ATRvD1. Tumor necrosis factor-α (TNF-α), IL-10, and IL-4 mRNA expression were increased in the kidney of BSA-challenged post-septic mice, and it was also reduced after ATRvD1. These results suggest that ATRvD1 protects the kidney against a second insult such as BSA-induced tubulointerstitial injury and fibrosis by suppressing inflammatory and pro-fibrotic mediators in renal dysfunction after sepsis.
format article
author José Bruno N. F. Silva
Thayanne B. B. Calcia
Cyntia P. Silva
Rafael F. Guilherme
Fernando Almeida-Souza
Felipe S. Lemos
Kátia S. Calabrese
Celso Caruso-Neves
Josiane S. Neves
Claudia F. Benjamim
author_facet José Bruno N. F. Silva
Thayanne B. B. Calcia
Cyntia P. Silva
Rafael F. Guilherme
Fernando Almeida-Souza
Felipe S. Lemos
Kátia S. Calabrese
Celso Caruso-Neves
Josiane S. Neves
Claudia F. Benjamim
author_sort José Bruno N. F. Silva
title ATRvD1 Attenuates Renal Tubulointerstitial Injury Induced by Albumin Overload in Sepsis-Surviving Mice
title_short ATRvD1 Attenuates Renal Tubulointerstitial Injury Induced by Albumin Overload in Sepsis-Surviving Mice
title_full ATRvD1 Attenuates Renal Tubulointerstitial Injury Induced by Albumin Overload in Sepsis-Surviving Mice
title_fullStr ATRvD1 Attenuates Renal Tubulointerstitial Injury Induced by Albumin Overload in Sepsis-Surviving Mice
title_full_unstemmed ATRvD1 Attenuates Renal Tubulointerstitial Injury Induced by Albumin Overload in Sepsis-Surviving Mice
title_sort atrvd1 attenuates renal tubulointerstitial injury induced by albumin overload in sepsis-surviving mice
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/bc27d461d16249e0bfb505668ad0236d
work_keys_str_mv AT josebrunonfsilva atrvd1attenuatesrenaltubulointerstitialinjuryinducedbyalbuminoverloadinsepsissurvivingmice
AT thayannebbcalcia atrvd1attenuatesrenaltubulointerstitialinjuryinducedbyalbuminoverloadinsepsissurvivingmice
AT cyntiapsilva atrvd1attenuatesrenaltubulointerstitialinjuryinducedbyalbuminoverloadinsepsissurvivingmice
AT rafaelfguilherme atrvd1attenuatesrenaltubulointerstitialinjuryinducedbyalbuminoverloadinsepsissurvivingmice
AT fernandoalmeidasouza atrvd1attenuatesrenaltubulointerstitialinjuryinducedbyalbuminoverloadinsepsissurvivingmice
AT felipeslemos atrvd1attenuatesrenaltubulointerstitialinjuryinducedbyalbuminoverloadinsepsissurvivingmice
AT katiascalabrese atrvd1attenuatesrenaltubulointerstitialinjuryinducedbyalbuminoverloadinsepsissurvivingmice
AT celsocarusoneves atrvd1attenuatesrenaltubulointerstitialinjuryinducedbyalbuminoverloadinsepsissurvivingmice
AT josianesneves atrvd1attenuatesrenaltubulointerstitialinjuryinducedbyalbuminoverloadinsepsissurvivingmice
AT claudiafbenjamim atrvd1attenuatesrenaltubulointerstitialinjuryinducedbyalbuminoverloadinsepsissurvivingmice
_version_ 1718432199567474688